ozempic glp 1 agonist The ABC's of GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare POTD: Wegovy and Ozempic —

In Phase 1 studies, survodutide was generally well tolerated, with no significant safety or tolerability issues observed in either healthy individuals with overweight or obesity [87, 88]

Also, high prices of GLP-1RAs due to their use in obesity management limit access to newer diabetes medicines in LMICs

In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]

The Y1R subtype is primarily expressed in osteoblasts

Unimolecular GLP-1-based polypharmacology Another more recently developed concept of polypharmacology is to combine some of the sequences of several structurally related hormones into a single entity of enhanced potency and sustained action

A recent comparison of GLP-1RAs versus placebo in both pediatric and adult populations demonstrated the significant efficacy of GLP-1RAs in promoting weight loss, highlighting their potential across diverse age groups (57)